META vs OPRA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
OPRA exhibits exceptional financial health with a perfect Piotroski F-Score of 9/9 and negligible debt (Debt/Equity 0.01). The stock is fundamentally undervalued, trading at $16.27, which is below both its Graham Number ($17.66) and significantly below its growth-based intrinsic value ($36.28). While technical trends and insider sentiment are currently bearish, the combination of 90.4% earnings growth and a strong 4.92% dividend yield presents a compelling value opportunity.
Compare Another Pair
Related Comparisons
META vs OPRA: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and Opera Limited (OPRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.